Related Experiment Video
Updated: Jul 26, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Anemia in chronic renal insufficiency--case report]
1Sluzba za unutrasnje bolesti, Zdravstveni centar Dr Gere Istvan, Senta. direktor@zdravstvosenta.co.yu
Medicinski Pregled
|October 13, 1999
Summary
Recombinant erythropoietin effectively treats anemia in patients with chronic renal insufficiency, improving their overall health and reducing the need for blood transfusions.
Area of Science:
- Nephrology
- Hematology
- Internal Medicine
Background:
- Chronic renal insufficiency (CRI) is a complex syndrome characterized by elevated serum urea and creatinine, often leading to anemia due to decreased erythropoietin synthesis and uremic toxins.
- Anemia in CRI is typically normocytic and normochromic, exacerbated by factors like decreased erythropoietin production, uremic toxins, microvascular kidney damage, and gastrointestinal bleeding.
- Recombinant erythropoietin (EPO) therapy has become crucial for managing anemia in CRI patients, administered via subcutaneous or intravenous routes with individualized dosing.
Observation:
- A 69-year-old female patient with CRI secondary to chronic pyelonephritis and hypertension experienced anemia requiring multiple erythrocyte transfusions.
- The patient was treated with subcutaneous recombinant erythropoietin (50 mcg/kg) every other day, with close monitoring of hemoglobin, hematocrit, erythrocyte count, and serum iron.
- Following initial treatment and a subsequent repeat course 14 months later, the patient showed a significant improvement in hemoglobin levels, reaching 92 g/L.
Findings:
- Recombinant erythropoietin therapy demonstrated a positive therapeutic response in correcting anemia associated with chronic renal insufficiency.
- The treatment led to a notable increase in hemoglobin and hematocrit levels, indicating effective stimulation of erythropoiesis.
- Serum iron levels were monitored to ensure adequate iron availability for erythropoiesis during EPO treatment.
Implications:
- This case report highlights the efficacy of recombinant erythropoietin in managing anemia in chronic renal insufficiency patients, leading to anemia correction.
- Successful EPO treatment reduces the necessity for frequent blood transfusions, thereby minimizing transfusion-related complications and improving the patient's general status.
- Recombinant erythropoietin offers a valuable therapeutic option for improving the quality of life for individuals suffering from anemia due to chronic kidney disease.
Related Concept Videos
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...